Last reviewed · How we verify

NCT04911569

Cryoneurolysis for Cutaneous Neuropathic Pain

Status unknown NA Last updated 3 June 2021
What this trial tests

NA trial testing Cryoneurolysis in Neuropathic Pain in 25 participants. Status unknown.

Timeline
7 June 2021
Primary endpoint
1 January 2023
1 January 2023

Quick facts

Lead sponsorAarhus University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment25
Start date7 June 2021
Primary completion1 January 2023
Estimated completion1 January 2023
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aarhus University Hospital

Who can join

18 and older, any sex, with Neuropathic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Feasibility study with 25 patients investigating the effect of cryoneurolysis on persistent cutaneous neuropathic pain after surgery and trauma. All patients receive active treatment (cryoneurolysis). The study design is unblinded, non-randomized, non-controlled.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cryoneurolysis

Trials testing the same drug.

Other recruiting trials for Neuropathic Pain

Currently open trials in the same condition.

Other Aarhus University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04911569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing